ESC Heart Failure:20万人研究!心衰患者的癌症发病风险更高,建议强化癌症筛查

2021-07-07 “心关注”公众号 “心关注”公众号

心衰患者的预后及生活质量,很大程度上取决于其并存疾病的种类及数量。据统计,西方国家心衰患者平均并存5类不同疾病,其中的癌症,是心衰患者非心血管死亡的主要原因之一。

心衰患者的预后及生活质量,很大程度上取决于其并存疾病的种类及数量。据统计,西方国家心衰患者平均并存5类不同疾病,其中的癌症,是心衰患者非心血管死亡的主要原因之一。

反过来看,心衰会不会明显增加癌症的发病率?德国学者发表在《ESC Heart Failure》杂志上的最新回顾性队列研究,分析了心衰与癌症发病的相关性。

研究者基于IQVIA疾病分析数据库,选取了2000年1月-2018年12月期间,德国1274家医疗中心中首次诊断为心衰的患者,并依据年龄、性别、肥胖及糖尿病等合并症匹配了同等数量的非心衰患者,统计两组患者的癌症发病率。

心衰组与非心衰组均纳入100124例患者,平均年龄72.6岁,女性占比54%,两组患者的糖尿病、肥胖患病率均为37.4%、15.9%,平均每年随访6次。

图1:两组患者的部分基线资料

01

心衰与癌症关联

经10年观察期记录,心衰组与非心衰组分别有25.7%、16.2%的患者被诊断为癌症。相比非心衰患者,心衰患者的癌症发病风险显着增加了76%。

图2:心衰、非心衰患者的10年癌症发病率KM曲线

02

男女性别差异

在女性患者中,心衰组与非心衰组患者的10年癌症发病率分别为28.6%、18.8%,女性心衰患者的癌症发病风险增加了85%。

在男性患者中,心衰组与非心衰组患者的10年癌症发病率分别为23.2%、13.8%,男性心衰患者的癌症发病风险增加了69%。

图3:男(左)、女(右)性别中,心衰组、非心衰组患者的10年癌症发病率

03

不同癌症种类

研究统计在内的各类癌症的发病风险,均与心衰显着相关。

其中,以唇癌、口腔癌和咽癌的相关性最强,心衰患者的发病风险增加110%。其次是呼吸系统癌症、女性生殖系统癌症、皮肤癌,在心衰患者中,其发病风险分别增加了91%、86%和83%。

图4:各类别癌症发病风险与心衰之间的关联

另外,还有淋巴与造血组织恶性肿瘤、消化系统癌症、乳腺癌、泌尿系统癌症、男性生殖系统癌症,在心衰患者中,其发病风险分别增加了77%、75%、67%、64%、52%。

04

发病机制关联

心衰与癌症之间的相关性,一方面可能存在共同的发病诱因,比如心衰患者的口咽癌发病率更高,可能与两病共同的外部诱因尼古丁等相关,以及共同的病理生理机制相关,比如慢性炎症、自由基生成增多等。

另一方面,心衰可能是一种致癌因素,能够诱发肿瘤细胞生成、促进肿瘤生长。比如最新动物实验数据显示,心衰会增加某些蛋白质的合成,激活致癌基因,促进肿瘤生长因子的分泌。

总之,该研究基于20万例心衰、非心衰患者数据,证实了心衰患者在病情发展过程中更高的癌症发病率。在临床诊疗及长期随访过程中,建议强化癌症筛查。

原始出处:

Christoph Roderburg, et al. Heart failure is associated with an increased incidence of cancer diagnoses. ESC Heart Failure. First published: 27 June 2021.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1906214, encodeId=8a48190621453, content=<a href='/topic/show?id=d7d3e2249e' target=_blank style='color:#2F92EE;'>#failure#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7224, encryptionId=d7d3e2249e, topicName=failure)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=010d202, createdName=amy0550, createdTime=Mon May 02 18:30:53 CST 2022, time=2022-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1357734, encodeId=49eb135e7340e, content=<a href='/topic/show?id=b0702e84b9' target=_blank style='color:#2F92EE;'>#ART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2784, encryptionId=b0702e84b9, topicName=ART)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Thu Jul 08 10:30:53 CST 2021, time=2021-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1373534, encodeId=eb9813e35348e, content=<a href='/topic/show?id=2fd051939ab' target=_blank style='color:#2F92EE;'>#心衰患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51939, encryptionId=2fd051939ab, topicName=心衰患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=467c360, createdName=yuanming7, createdTime=Thu Jul 08 10:30:53 CST 2021, time=2021-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1536143, encodeId=407f153614330, content=<a href='/topic/show?id=d0c6e1458e2' target=_blank style='color:#2F92EE;'>#癌症筛查#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71458, encryptionId=d0c6e1458e2, topicName=癌症筛查)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Thu Jul 08 10:30:53 CST 2021, time=2021-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1563483, encodeId=ea2315634836f, content=<a href='/topic/show?id=f69d864413' target=_blank style='color:#2F92EE;'>#HEART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8644, encryptionId=f69d864413, topicName=HEART)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80d715270048, createdName=slcumt, createdTime=Thu Jul 08 10:30:53 CST 2021, time=2021-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=997294, encodeId=bb0f99e294b1, content=心衰患者, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1f221859736, createdName=ms2658711348342440, createdTime=Wed Jul 07 20:51:08 CST 2021, time=2021-07-07, status=1, ipAttribution=)]
    2022-05-02 amy0550
  2. [GetPortalCommentsPageByObjectIdResponse(id=1906214, encodeId=8a48190621453, content=<a href='/topic/show?id=d7d3e2249e' target=_blank style='color:#2F92EE;'>#failure#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7224, encryptionId=d7d3e2249e, topicName=failure)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=010d202, createdName=amy0550, createdTime=Mon May 02 18:30:53 CST 2022, time=2022-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1357734, encodeId=49eb135e7340e, content=<a href='/topic/show?id=b0702e84b9' target=_blank style='color:#2F92EE;'>#ART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2784, encryptionId=b0702e84b9, topicName=ART)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Thu Jul 08 10:30:53 CST 2021, time=2021-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1373534, encodeId=eb9813e35348e, content=<a href='/topic/show?id=2fd051939ab' target=_blank style='color:#2F92EE;'>#心衰患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51939, encryptionId=2fd051939ab, topicName=心衰患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=467c360, createdName=yuanming7, createdTime=Thu Jul 08 10:30:53 CST 2021, time=2021-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1536143, encodeId=407f153614330, content=<a href='/topic/show?id=d0c6e1458e2' target=_blank style='color:#2F92EE;'>#癌症筛查#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71458, encryptionId=d0c6e1458e2, topicName=癌症筛查)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Thu Jul 08 10:30:53 CST 2021, time=2021-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1563483, encodeId=ea2315634836f, content=<a href='/topic/show?id=f69d864413' target=_blank style='color:#2F92EE;'>#HEART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8644, encryptionId=f69d864413, topicName=HEART)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80d715270048, createdName=slcumt, createdTime=Thu Jul 08 10:30:53 CST 2021, time=2021-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=997294, encodeId=bb0f99e294b1, content=心衰患者, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1f221859736, createdName=ms2658711348342440, createdTime=Wed Jul 07 20:51:08 CST 2021, time=2021-07-07, status=1, ipAttribution=)]
    2021-07-08 zhaojie88
  3. [GetPortalCommentsPageByObjectIdResponse(id=1906214, encodeId=8a48190621453, content=<a href='/topic/show?id=d7d3e2249e' target=_blank style='color:#2F92EE;'>#failure#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7224, encryptionId=d7d3e2249e, topicName=failure)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=010d202, createdName=amy0550, createdTime=Mon May 02 18:30:53 CST 2022, time=2022-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1357734, encodeId=49eb135e7340e, content=<a href='/topic/show?id=b0702e84b9' target=_blank style='color:#2F92EE;'>#ART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2784, encryptionId=b0702e84b9, topicName=ART)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Thu Jul 08 10:30:53 CST 2021, time=2021-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1373534, encodeId=eb9813e35348e, content=<a href='/topic/show?id=2fd051939ab' target=_blank style='color:#2F92EE;'>#心衰患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51939, encryptionId=2fd051939ab, topicName=心衰患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=467c360, createdName=yuanming7, createdTime=Thu Jul 08 10:30:53 CST 2021, time=2021-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1536143, encodeId=407f153614330, content=<a href='/topic/show?id=d0c6e1458e2' target=_blank style='color:#2F92EE;'>#癌症筛查#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71458, encryptionId=d0c6e1458e2, topicName=癌症筛查)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Thu Jul 08 10:30:53 CST 2021, time=2021-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1563483, encodeId=ea2315634836f, content=<a href='/topic/show?id=f69d864413' target=_blank style='color:#2F92EE;'>#HEART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8644, encryptionId=f69d864413, topicName=HEART)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80d715270048, createdName=slcumt, createdTime=Thu Jul 08 10:30:53 CST 2021, time=2021-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=997294, encodeId=bb0f99e294b1, content=心衰患者, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1f221859736, createdName=ms2658711348342440, createdTime=Wed Jul 07 20:51:08 CST 2021, time=2021-07-07, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1906214, encodeId=8a48190621453, content=<a href='/topic/show?id=d7d3e2249e' target=_blank style='color:#2F92EE;'>#failure#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7224, encryptionId=d7d3e2249e, topicName=failure)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=010d202, createdName=amy0550, createdTime=Mon May 02 18:30:53 CST 2022, time=2022-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1357734, encodeId=49eb135e7340e, content=<a href='/topic/show?id=b0702e84b9' target=_blank style='color:#2F92EE;'>#ART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2784, encryptionId=b0702e84b9, topicName=ART)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Thu Jul 08 10:30:53 CST 2021, time=2021-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1373534, encodeId=eb9813e35348e, content=<a href='/topic/show?id=2fd051939ab' target=_blank style='color:#2F92EE;'>#心衰患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51939, encryptionId=2fd051939ab, topicName=心衰患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=467c360, createdName=yuanming7, createdTime=Thu Jul 08 10:30:53 CST 2021, time=2021-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1536143, encodeId=407f153614330, content=<a href='/topic/show?id=d0c6e1458e2' target=_blank style='color:#2F92EE;'>#癌症筛查#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71458, encryptionId=d0c6e1458e2, topicName=癌症筛查)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Thu Jul 08 10:30:53 CST 2021, time=2021-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1563483, encodeId=ea2315634836f, content=<a href='/topic/show?id=f69d864413' target=_blank style='color:#2F92EE;'>#HEART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8644, encryptionId=f69d864413, topicName=HEART)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80d715270048, createdName=slcumt, createdTime=Thu Jul 08 10:30:53 CST 2021, time=2021-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=997294, encodeId=bb0f99e294b1, content=心衰患者, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1f221859736, createdName=ms2658711348342440, createdTime=Wed Jul 07 20:51:08 CST 2021, time=2021-07-07, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1906214, encodeId=8a48190621453, content=<a href='/topic/show?id=d7d3e2249e' target=_blank style='color:#2F92EE;'>#failure#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7224, encryptionId=d7d3e2249e, topicName=failure)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=010d202, createdName=amy0550, createdTime=Mon May 02 18:30:53 CST 2022, time=2022-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1357734, encodeId=49eb135e7340e, content=<a href='/topic/show?id=b0702e84b9' target=_blank style='color:#2F92EE;'>#ART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2784, encryptionId=b0702e84b9, topicName=ART)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Thu Jul 08 10:30:53 CST 2021, time=2021-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1373534, encodeId=eb9813e35348e, content=<a href='/topic/show?id=2fd051939ab' target=_blank style='color:#2F92EE;'>#心衰患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51939, encryptionId=2fd051939ab, topicName=心衰患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=467c360, createdName=yuanming7, createdTime=Thu Jul 08 10:30:53 CST 2021, time=2021-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1536143, encodeId=407f153614330, content=<a href='/topic/show?id=d0c6e1458e2' target=_blank style='color:#2F92EE;'>#癌症筛查#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71458, encryptionId=d0c6e1458e2, topicName=癌症筛查)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Thu Jul 08 10:30:53 CST 2021, time=2021-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1563483, encodeId=ea2315634836f, content=<a href='/topic/show?id=f69d864413' target=_blank style='color:#2F92EE;'>#HEART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8644, encryptionId=f69d864413, topicName=HEART)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80d715270048, createdName=slcumt, createdTime=Thu Jul 08 10:30:53 CST 2021, time=2021-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=997294, encodeId=bb0f99e294b1, content=心衰患者, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1f221859736, createdName=ms2658711348342440, createdTime=Wed Jul 07 20:51:08 CST 2021, time=2021-07-07, status=1, ipAttribution=)]
    2021-07-08 slcumt
  6. [GetPortalCommentsPageByObjectIdResponse(id=1906214, encodeId=8a48190621453, content=<a href='/topic/show?id=d7d3e2249e' target=_blank style='color:#2F92EE;'>#failure#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7224, encryptionId=d7d3e2249e, topicName=failure)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=010d202, createdName=amy0550, createdTime=Mon May 02 18:30:53 CST 2022, time=2022-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1357734, encodeId=49eb135e7340e, content=<a href='/topic/show?id=b0702e84b9' target=_blank style='color:#2F92EE;'>#ART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2784, encryptionId=b0702e84b9, topicName=ART)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Thu Jul 08 10:30:53 CST 2021, time=2021-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1373534, encodeId=eb9813e35348e, content=<a href='/topic/show?id=2fd051939ab' target=_blank style='color:#2F92EE;'>#心衰患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51939, encryptionId=2fd051939ab, topicName=心衰患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=467c360, createdName=yuanming7, createdTime=Thu Jul 08 10:30:53 CST 2021, time=2021-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1536143, encodeId=407f153614330, content=<a href='/topic/show?id=d0c6e1458e2' target=_blank style='color:#2F92EE;'>#癌症筛查#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71458, encryptionId=d0c6e1458e2, topicName=癌症筛查)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Thu Jul 08 10:30:53 CST 2021, time=2021-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1563483, encodeId=ea2315634836f, content=<a href='/topic/show?id=f69d864413' target=_blank style='color:#2F92EE;'>#HEART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8644, encryptionId=f69d864413, topicName=HEART)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80d715270048, createdName=slcumt, createdTime=Thu Jul 08 10:30:53 CST 2021, time=2021-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=997294, encodeId=bb0f99e294b1, content=心衰患者, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1f221859736, createdName=ms2658711348342440, createdTime=Wed Jul 07 20:51:08 CST 2021, time=2021-07-07, status=1, ipAttribution=)]
    2021-07-07 ms2658711348342440

    心衰患者

    0

相关资讯

JAMA:癌症筛查不能阻止卵巢癌兴风作浪?

肿瘤并非一夜形成,通过一些早期的筛查手段可尽早发现肿瘤的迹象,扼杀肿瘤于萌芽。但有专家认为早期筛查耗费人力、物力,有时还有创伤性检查,并非对所有肿瘤都适用。卵巢癌相对罕见,却是美国女性死亡的第五大原因。那早期筛查能否阻止卵巢癌兴风作浪,降低死亡率呢?

英国癌症筛查计划将获得独立审查

英国NHS将启动一项重大的癌症筛查工作,用以改善护理和挽救生命。英国前国家癌症主任Mike Richards教授将主持对国家筛查计划的独立审查。

Lancet Oncology:乳腺癌筛查,究竟几岁开始更合适?23年随访数据引发探讨

乳腺钼靶(X线检查)是乳腺癌筛查的重要手段,筛查对于早诊早治、改善生存率的积极意义也已经得到大量研究支持。然而,仍然存有争议的一个问题是:哪个年龄范围最适合开始乳腺癌筛查?

JAMA Netw Open:癌症筛查可降低全因死亡率,但仍需个体化!

癌症筛查早期发现仍是癌症和癌前病变的重要途径!

Thorax:使用12个月序贯体积筛查肺结节的癌症概率

该模型可用于估算在基线、基线后3个月和12个月检测到结节的肺癌概率,从而在人群肺癌筛查项目可以更有效地对随访进行分层。

妇女“两癌”筛查体检报告4个月后送达 主管部门承认工作有“瑕疵”

妇女“两癌”筛查是全国妇联、卫健部门开展的“宫颈癌和乳腺癌”检查活动,其目的是第一时间排查病患,让患者做到早发现、早诊断、早治疗。然而,江苏响水一女子参加“两癌”筛查体检的报告却在4个月后才送达,对此,当地卫生部门官员表示报告“迟到”事出有因,是工作中的一个“瑕疵”。张丽娟是江苏响水爱普森制药厂的员工。2018年5月23日,响水县卫计委安排其下属单位妇幼保健计划生育服务中心,委托双港镇卫生院到爱普